Literature DB >> 952292

Hereditary antithrombin III deficiency. Effect of antithrombin III deficiency on platelet function.

A Carvalho, L Ellman.   

Abstract

Antithrombin III (AT III) is the main physiologic inhibitor of thrombin, and activated factors X and IX as well. Normal levels of AT III appear to be necessary to maintain blood fluidity and to prevent thrombosis. Four families with AT III deficiency and recurrent venous thromboembolism have been reported on. We present an additional family with AT III deficiency and a high incidence of thromboembolism. AT III levels were determined by both a functional and an immunologic assay. Results of platelet function tests, not previously reported in persons with AT III deficiency, were found to be normal. Following gel filtration, the platelets were very sensitive to thrombin. Thrombin-induced platelet aggregation appears to be dependent on a balance between the amount of thrombin and AT III present.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 952292     DOI: 10.1016/0002-9343(76)90167-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

Review 1.  Familial venous thrombosis.

Authors:  J H Winter; A S Douglas
Journal:  Postgrad Med J       Date:  1983-11       Impact factor: 2.401

2.  Antithrombin III deficiency, hypertriglyceridaemia, and venous thromboses.

Authors:  O H Gyde; M D Middleton; G R Vaughan; D J Fletcher
Journal:  Br Med J       Date:  1978-03-11

3.  Determination of antithrombin activity by an amidolytic and a clotting procedure.

Authors:  A Frigola; S Angeloni; A R Cerqueti
Journal:  J Clin Pathol       Date:  1979-01       Impact factor: 3.411

4.  Familial thrombosis: inherited deficiency of antithrombin III.

Authors:  M Mackie; B Bennett; D Ogston; A S Douglas
Journal:  Br Med J       Date:  1978-01-21

5.  Relation between antithrombin III and clinical and serological parameters in systemic lupus erythematosus.

Authors:  M P Jarrett; D Green; C H Ts'ao
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

6.  Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.

Authors:  K A Bauer; T L Goodman; B L Kass; R D Rosenberg
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.